Grant funds will establish the CAPCell center, which will use artificial intelligence to optimize stem cell bioprocess control, monitoring, production yield and quality.

CAPCell is a multi-disciplinary initiative integrating artificial intelligence, bioprocesses and cell manufacturing technology to advance stem cell research.

This appears to be an early effort to apply production AI control systems directly to live cell manufacturing workflows. No launch timeline for the center has been included in the filed reports.